Director, APAC Evidence & Access Strategy – Ion

Benefits

Parental leave

8 weeks Verified - employer source source checked May 7, 2026

Non-birth-parent leave

8 weeks Verified - employer source source checked May 7, 2026

Family-building benefits

• Fertility benefits: Not verified
• Adoption assistance: Not verified
• Surrogacy assistance: Not verified

Mental health support

Not verified

Relocation assistance

Not verified

Childcare support

Not verified

Learning budget

Not verified

Verification

Source-linked checked May 7, 2026

Salary

Not verified

Was this benefit information wrong? Tell us.

Market context

U.S. role benchmark (BLS OEWS)

$61,842 U.S. median for this role

Projected growth (BLS Employment Projections)

+1.9% - Slower

Matched to SOC 11-1021 - Operations aggregate by role bucket.

Source: U.S. Bureau of Labor Statistics, OEWS, May 2024 and Employment Projections, 2024-2034.

Schedule

Shift type

Not verified

Weekend work

Not verified

Company

Company stage

Public-company Verified - from the job posting source checked Jun 20, 2026

Application

Cover letter

Not verified

Assessment

Not verified

Deadline

Not stated

Where they hire

State eligibility is not yet verified.

About this role

Director, APAC Evidence & Access Strategy – Ion Remote | Tokyo, JAPAN, Japan 企業概要: 求人内容: Primary Function of Position This role leads the clinical, economic, and access-focused evidence strategy for the Ion Business Unit across priority Asia Pacific (APAC) markets. You own the regional strategy that shows how Ion improves patient outcomes, care pathways, and health-system efficiency - and you use that evidence to unlock and scale access, reimbursement, and adoption. This role will work closely with APAC Commercial, Country GMs, Clinical Affairs, Product Management, Clinical Development Engineering, Medical Office, and Clinical Marketing, and collaborate with the Global Access Value and Economics(GAVE) team. Key Responsibilities  Set the APAC evidence & access strategy Define a 3-5 year clinical and economic evidence roadmap for Ion in APAC, linked to clear access, reimbursement, and adoption milestones in priority markets.  Design and deliver high-impact evidence Lead design and prioritization of clinical and economic studies (clinical outcomes, RWE, cost effectiveness, budget impact, pathway/resource use) that answer payer, HTA, hospital, and clinical decision-maker questions.  Translate data into value stories Turn evidence into locally relevant value propositions, dossiers, slide decks, tools, and decision aids for payers, HTA bodies, hospital value committees, and clinical champions.  Develop access pathways Develop APAC access plans (eg. HTA routes, innovation funding, direct payer contracting, hospital funding logic, coding/reimbursement context), and supply the Ion-specific evidence and analytics needed for submissions and negotiations, without owning pricing or commercial terms.  Act as the regional Ion “go-to” for evidence & access

Read the full description at jobs.smartrecruiters.com. FewerJobs shows a preview and links to the original posting.